MDCO - The Medicines Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
6,138
44,789
167,835
Cost of Revenue
697
7,255
47,193
71,347
Gross Profit
-697
-1,117
-2,404
96,488
Operating Expenses
Research Development
127,504
133,007
138,370
139,262
Selling General and Administrative
50,894
52,214
132,225
319,151
Total Operating Expenses
178,398
185,221
270,595
458,413
Operating Income or Loss
-179,095
-186,338
-272,999
-361,925
Interest Expense
60,940
49,411
48,564
44,463
Total Other Income/Expenses Net
-1,664
-50,355
-382,708
287,102
Income Before Tax
-241,699
-286,104
-704,271
-119,286
Income Tax Expense
-3,493
-50,888
-96,576
70
Income from Continuing Operations
-238,206
-235,216
-607,695
-119,356
Net Income
-236,388
-123,156
-708,373
-119,118
Net Income available to common shareholders
-236,388
-123,156
-708,373
-119,118
Reported EPS
Basic
-
-1.68
-9.79
-1.71
Diluted
-
-1.68
-9.79
-1.71
Weighted average shares outstanding
Basic
-
73,571
72,356
69,909
Diluted
-
73,571
72,356
69,909
EBITDA
-
-236,693
-655,707
-74,823